Tessa Brabander

Tessa Brabander is a Researcher at the Department of Radiology & Nuclear Medicine, Erasmus MC. Her work focuses on radionuclide therapy applications, particularly in neuroendocrine tumors, prostate cancer, and cardiac sarcoidosis. Key contributions include advancements in PET/MR imaging techniques, peptide receptor targeting strategies, and actinium-225 radiochemistry. She has published extensively on radioisotope pharmacology and clinical outcomes of targeted therapies.

• Specializes in therapeutic radiology applications
• Expertise in radiochemistry synthesis and quality control
• Active in multidisciplinary tumor treatment protocols

Her research integrates diagnostic imaging innovations with precision oncology, emphasizing translational research from preclinical developments to clinical implementation. Recent work addresses unmet treatment needs in metastatic cancers beyond standard criteria. Collaborations span nuclear medicine, oncology, and cardiology disciplines.

Contributions include over 60 peer-reviewed publications and supervision of research projects. Current focus areas include optimizing radionuclide delivery systems and improving diagnostic accuracy for inflammatory cardiac conditions.